Get the Stockscreener App
2.65
9.86%
-0.29
After Hours:
2.78
0.13
+4.91%
Bioline Rx Ltd Adr Stock (BLRX) Forecast
The Bioline Rx Ltd Adr (BLRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.566, representing a -3.17% decrease from the current price of $2.65. The highest analyst price target is $2.7276, and the lowest is $2.4045.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BLRX Price Target
Average 1.4393
(-45.69% Downside)
Is Bioline Rx Ltd Adr (BLRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.19 | Neutral |
| STOCH(9,6) | 12.20 | Buy |
| STOCHRSI(14) | 7.3721 | Buy |
| MACD(12,26) | -0.0337 | Sell |
| ADX(14) | 27.96 | Sell |
| William %R | -93.38 | Buy |
| CCI(14) | -168.42 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.074
Sell
|
3.0179
Sell
|
| MA20 |
3.1625
Sell
|
3.0998
Sell
|
| MA50 |
3.0831
Sell
|
2.7656
Sell
|
| MA100 |
1.6707
Buy
|
2.1201
Buy
|
| MA200 |
1.1422
Buy
|
1.5836
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, BLRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 7 Buy signals, 9 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on BLRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.19 indicates that BLRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.2 indicates that BLRX is oversold. This indicates that BLRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.3721 indicates that BLRX is oversold. This suggests that BLRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.96 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -168.42 indicates that BLRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BLRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bioline Rx Ltd Adr financial reports and earnings history, Bioline Rx Ltd Adr (BLRX) stock could reach $4.2511 by 2030, $3.5567 by 2040 and $10.75 by 2050. See the projected annual prices until 2050 of the Bioline Rx Ltd Adr stock below:
- Bioline Rx Ltd Adr (BLRX) is expected to reach an average price of $0.4943 in 2035, with a high prediction of $0.5393 and a low estimate of $0.4943. This indicates an $-81.35% rise from the last recorded price of $2.65.
- Bioline Rx Ltd Adr (BLRX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3724, representing an $27.26% surge from its current level. The forecast ranges from a conservative $3.4224 to a sky-high $3.5567.
- Our analysts predict Bioline Rx Ltd Adr (BLRX) to jump 161.09% by 2045, soaring from $6.5726 to an average price of $6.9189, potentially reaching $6.9266. While $6.5726 is the low estimate, the potential upside is significant.
- Bioline Rx Ltd Adr (BLRX) stock is expected to climb by 2050, reaching an average of $10.62, a $300.62% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.75 and $10.74, respectively, highlighting the market's uncertainty.
Bioline Rx Ltd Adr Stock (BLRX) Year by Year Forecast
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2025
Bioline Rx Ltd Adr Stock (BLRX) is expected to reach an average price of $2.2289 in 2025, with a high prediction of $2.7563 and a low estimate of $1.7014. This indicates an -15.89% fall from the last recorded price of $2.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $2.3845 | $2.4045 | $2.7276 | -10.02% |
| June, 2025 | $2.337 | $2.3714 | $2.3157 | -11.81% |
| July, 2025 | $2.1051 | $2.2109 | $2.1639 | -20.56% |
| August, 2025 | $2.0277 | $2.1577 | $2.102 | -23.48% |
| September, 2025 | $1.6102 | $1.7645 | $1.8433 | -39.24% |
| October, 2025 | $2.0383 | $1.7014 | $1.8383 | -23.08% |
| November, 2025 | $2.0108 | $2.0496 | $1.9658 | -24.12% |
| December, 2025 | $1.599 | $2.0377 | $2.0021 | -39.66% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2026
The predicted value for Bioline Rx Ltd Adr (BLRX) in 2026 is set at an average of $1.594. Estimates vary from a peak of $3.1778 to a trough of $0.0102, indicating an -39.85% surge from the present price of $2.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2015 | $1.3515 | $1.0065 | -54.66% |
| February, 2026 | $0.864 | $1.064 | $1.1972 | -67.40% |
| March, 2026 | $0.6265 | $0.7265 | $0.8355 | -76.36% |
| April, 2026 | $0.00467 | $0.151 | $0.881 | -99.82% |
| May, 2026 | $0.2172 | $0.3249 | $0.4197 | -91.80% |
| June, 2026 | $0.3497 | $0.4341 | $0.3484 | -86.80% |
| July, 2026 | $0.2978 | $0.0522 | $3.1778 | -88.76% |
| August, 2026 | $0.3004 | $0.2991 | $0.1904 | -88.67% |
| September, 2026 | $0.1815 | $0.0985 | $0.6005 | -93.15% |
| October, 2026 | $0.189 | $0.0102 | $0.4309 | -92.87% |
| November, 2026 | $0.0335 | $0.0334 | $0.2034 | -98.73% |
| December, 2026 | $0.0817 | $0.1092 | $0.1208 | -96.92% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bioline Rx Ltd Adr (BLRX) is $0.5327, with a high forecast of $1.0399 and a low forecast of $0.0255. This indicates an -79.90% decrease from the last price of $2.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1158 | $0.0758 | $0.3613 | -95.63% |
| February, 2027 | $0.0567 | $0.0255 | $0.2433 | -97.86% |
| March, 2027 | $0.3349 | $0.1523 | $0.3608 | -87.36% |
| April, 2027 | $0.5774 | $0.4805 | $0.5175 | -78.21% |
| May, 2027 | $0.7699 | $0.7929 | $0.6786 | -70.95% |
| June, 2027 | $0.908 | $0.8155 | $0.8624 | -65.73% |
| July, 2027 | $0.6905 | $0.7505 | $0.8437 | -73.94% |
| August, 2027 | $0.9131 | $0.6962 | $0.8031 | -65.54% |
| September, 2027 | $0.6912 | $1.1043 | $1.0399 | -73.92% |
| October, 2027 | $0.9137 | $0.7925 | $0.8337 | -65.52% |
| November, 2027 | $0.6862 | $0.8993 | $0.8506 | -74.10% |
| December, 2027 | $0.2144 | $0.4644 | $0.7531 | -91.91% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2028
In 2028, Bioline Rx Ltd Adr (BLRX) is projected to reach an average price of $0.5936, with a high projection of $1.1538 and a low estimate of $0.0333. This indicates an -77.60% fall from the last price of $2.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5269 | $0.42 | $0.4769 | -80.12% |
| February, 2028 | $1.0444 | $0.5225 | $1.0184 | -60.59% |
| March, 2028 | $1.0504 | $1.0676 | $1.0519 | -60.36% |
| April, 2028 | $1.1479 | $1.0568 | $1.1301 | -56.68% |
| May, 2028 | $1.1882 | $1.135 | $1.1187 | -55.16% |
| June, 2028 | $1.0327 | $1.0407 | $1.1538 | -61.03% |
| July, 2028 | $1.0542 | $1.0676 | $1.0468 | -60.22% |
| August, 2028 | $1.0123 | $1.0314 | $1.0189 | -61.80% |
| September, 2028 | $0.5264 | $0.642 | $0.9521 | -80.14% |
| October, 2028 | $0.2764 | $0.4064 | $0.3152 | -89.57% |
| November, 2028 | $0.2654 | $0.0333 | $0.2854 | -89.98% |
| December, 2028 | $0.2579 | $0.1699 | $0.4541 | -90.27% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2029
The 2029 price forecast for Bioline Rx Ltd Adr Stock (BLRX) is $1.5107 on average, with a high prediction of $3.0148 and a low estimate of $0.00664. This represents an -42.99% decrease from the previous price of $2.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2748 | $0.0196 | $0.4517 | -89.63% |
| February, 2029 | $0.0323 | $0.00774 | $0.3691 | -98.78% |
| March, 2029 | $0.7997 | $0.00664 | $1.3654 | -69.82% |
| April, 2029 | $0.5072 | $0.2472 | $1.1641 | -80.86% |
| May, 2029 | $0.4091 | $0.186 | $0.6291 | -84.56% |
| June, 2029 | $0.5566 | $0.3735 | $0.9235 | -79.00% |
| July, 2029 | $0.6641 | $0.5509 | $0.9409 | -74.94% |
| August, 2029 | $0.3559 | $0.2015 | $0.7028 | -86.57% |
| September, 2029 | $0.4034 | $0.2047 | $0.489 | -84.78% |
| October, 2029 | $0.6753 | $0.3865 | $0.6965 | -74.52% |
| November, 2029 | $0.00924 | $0.0116 | $0.6596 | -99.65% |
| December, 2029 | $4.1428 | $0.0176 | $3.0148 | +56.33% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2030
Bioline Rx Ltd Adr Stock (BLRX) is expected to reach an average price of $5.4811 in 2030, with a high forecast of $6.8527 and a low forecast of $4.1096. This signifies an +106.84% surge from the last price of $2.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.2856 | $4.2936 | $4.2511 | +61.72% |
| February, 2030 | $4.8111 | $4.1096 | $4.2711 | +81.55% |
| March, 2030 | $5.4011 | $5.4261 | $5.1988 | +103.82% |
| April, 2030 | $6.2712 | $6.2198 | $6.0012 | +136.65% |
| May, 2030 | $6.3974 | $6.37 | $6.3875 | +141.41% |
| June, 2030 | $6.1725 | $6.2125 | $6.0725 | +132.92% |
| July, 2030 | $6.0888 | $6.1688 | $6.1338 | +129.77% |
| August, 2030 | $6.6752 | $6.1308 | $6.2338 | +151.90% |
| September, 2030 | $6.1098 | $6.1688 | $6.1551 | +130.56% |
| October, 2030 | $6.2951 | $6.0514 | $6.1251 | +137.55% |
| November, 2030 | $6.8702 | $6.3364 | $6.3402 | +159.25% |
| December, 2030 | $6.8752 | $6.9239 | $6.8527 | +159.44% |
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):